1. Ankylosing spondylitis and glaucoma in European population: A Mendelian randomization study.
- Author
-
Li S, Chen M, Zhang Q, Fang M, Xiong W, and Bai L
- Subjects
- Humans, Genome-Wide Association Study, Mendelian Randomization Analysis, Spondylitis, Ankylosing, Glaucoma, Open-Angle, Glaucoma
- Abstract
Background: The relationship between ankylosing spondylitis (AS) and glaucoma in the European population remains unclear. In the present study, we applied a two-sample Mendelian randomization (MR) method to investigate their causal relationship., Methods: MR analysis was conducted to validate the causal associations between AS with glaucoma using summary statistics from the genome-wide association studies of AS (9,069 cases and 13,578 control subjects) and glaucoma (8,591 cases and 210,201 control subjects). The inverse variance weighting method was performed to evaluate the causal relationship. The MR-Egger regression approach was applied to assess pleiotropy, while Cochran's Q test was used to analyze heterogeneity. Subgroup analysis was performed according to primary open-angle glaucoma (POAG) and primary angle-closure glaucoma (PACG)., Results: The results of the MR study reveal a risk-increasing causal relationship between AS and glaucoma among European populations (OR = 1.35, 95%CI = 1.16-1.57, P = 8.81 × 10
-5 ). Pleiotropy and heterogeneity were not found in our study. In the subgroup analysis, AS was also causal with POAG (OR = 1.48, 95%CI = 1.17-1.86, P = 8.80 × 10-4 ) and PACG (OR = 1.91, 95%CI = 1.03-3.51, P = 3.88 × 10-2 )., Conclusion: The results of the MR analysis suggested a causal relationship between AS and glaucoma in the European population. Further studies are needed to identify the specific mechanism between these two diseases., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Li, Chen, Zhang, Fang, Xiong and Bai.)- Published
- 2023
- Full Text
- View/download PDF